Connect with us

Business

The Legend of Zelda: Tears of the Kingdom Ver. 1.4.3 Patch Notes: Black Hinox Bug Fixed

Published

on

The Legend of Zelda: Tears of the Kingdom

Nintendo has released version 1.4.3 for The Legend of Zelda: Tears of the Kingdom, addressing a persistent bug that prevented some players from earning a key collectible after defeating a formidable Black Hinox in Hyrule Castle, the company announced Monday.

The Legend of Zelda: Tears of the Kingdom
The Legend of Zelda: Tears of the Kingdom

The update, which rolled out globally on Feb. 17, 2026, for both Nintendo Switch and Nintendo Switch 2 consoles, fixes an issue where the Black Hinox — a rare, one-eyed cyclops miniboss lurking in the depths beneath Hyrule Castle — would incorrectly display as “undefeated” even after players vanquished it. This glitch blocked completionists from obtaining the Hinox Monster Medal, a trophy essential for advancing the Monster Control Crew side adventure and unlocking cosmetic monster masks at the Tarrey Town theater.

“By downloading the update data, players will be able to obtain the Hinox Monster Medal,” Nintendo stated in its official patch notes, ensuring retroactive credit for those already affected. The changelog also notes that “several other issues have been addressed to improve the gameplay experience,” though specifics remain undisclosed — a common practice for minor stability tweaks.

The Black Hinox bug had frustrated dedicated explorers since at least mid-2025, with players reporting on forums like Reddit that the beast failed to register as defeated despite confirmed kills during quests in the castle’s subterranean library area. One Reddit user in April 2025 questioned its spawn, while others shared videos of despawning glitches in related caves. Social media sleuth OatmealDome highlighted the fix on X, posting official Japanese notes that mirrored the English version.

This patch arrives amid Nintendo’s yearlong celebration of the Zelda franchise’s 40th anniversary, marking the 1986 debut of The Legend of Zelda on the Famicom. Both Tears of the Kingdom and its predecessor Breath of the Wild received simultaneous updates, with the latter jumping to version 1.9.0. That patch adds Thai language support for Switch 2 (text-only, with English audio fallback) and general fixes, underscoring Nintendo’s commitment to its evergreen titles.

Advertisement

Since its May 2023 launch, Tears of the Kingdom has sold over 21 million copies worldwide, cementing its status as one of the best-selling Switch games and a critical darling with a 96/100 Metacritic score. Nintendo has supported it with 20+ patches, evolving from launch-day crashes to quality-of-life enhancements like amiibo unlocks for Sage figures (Sidon, Tulin, Yunobo, Riju) and Portuguese (Brazil) text revisions.

Update Version Release Date Key Changes
1.4.3 Feb. 17, 2026 Black Hinox fix; general stability.
1.4.2 Late 2025 Switch 2 Edition support; new amiibo.
1.2.1 2023 Quest progression fixes (e.g., “Camera Work in the Depths”).
1.1.0 Launch Initial stability patches.

The update coincides with enhanced Switch 2 compatibility, including paid upgrades via Nintendo Switch Online + Expansion Pack. Players on original hardware need not upgrade to benefit from the fix, which applies universally.

Community response has been muted but positive, given the niche nature of the bug. On X, Spanish outlet TLoZeldaES noted the medal unlock, while ZELDCAST praised fixes across both games. Nintendo Life comments joked about the Thai addition (“It’s about Thai-me!”) and lamented lack of Wii U support, but many appreciated the free longevity boost: “Free updates = more stable horse games.”

To install, connect your console to the internet, highlight the game icon on the HOME Menu, press + or – , select “Software Update” > “Via the Internet.” Auto-updates are recommended for seamless delivery. Save data remains intact.

Advertisement

Nintendo’s ongoing tweaks reflect a philosophy of polish over abandonment, especially as rumors swirl of a new 3D Zelda for Switch 2. With Tears of the Kingdom‘s Ultrahand and Fuse mechanics still inspiring fan creations, this patch ensures every corner of Hyrule — even its darkest castles — yields its rewards.

The fix arrives just in time for anniversary events, including potential in-game bonuses tied to Switch News channels. As one X user quipped, “Now I can finally complete my monster collection without exploits.”

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Defence giant BAE hails record sales as workers remain on strike

Published

on

Defence giant BAE hails record sales as workers remain on strike

Speaking after the company’s record results, Woodburn, who has run BAE since 2017, said: “In a new era of defence spending, driven by escalating security challenges, we’re well-positioned to provide both the advanced conventional systems and disruptive technologies needed to protect the nations we serve now and into the future.”

Continue Reading

Business

Lagarde’s possible early departure leaves investors pondering replacements

Published

on

Lagarde’s possible early departure leaves investors pondering replacements


Lagarde’s possible early departure leaves investors pondering replacements

Continue Reading

Business

Upstart’s Technology Has Taken The Next Step (Rating Upgrade) (NASDAQ:UPST)

Published

on

Upstart's Technology Has Taken The Next Step (Rating Upgrade) (NASDAQ:UPST)

This article was written by

I am an individual investor, working at a global technology company. I have an academic background in engineering and business economics and am currently pursuing a PhD in economics. I started investing while attending university in 2012 and have a focus in technology-based growth stocks, particularly in the fields of renewable energy, hydrogen, new mobility and space. As I aim to identify growth stocks for a diversified portfolio early on, the companies I invest in are usually small or micro caps which are not covered by a lot of analysts and SA contributors. I will thus share my thoughts from time to time with articles if I feel there are interesting yet under-evaluated investment ideas to contribute. My investment style is long only and I invest to hold for the long-term. In my analyses, I focus on fundamental topics such as technology, business model and valuation relative to the addressed market.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of UPST, PGY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

General Mills reduces forecast for fiscal 2026

Published

on

General Mills reduces forecast for fiscal 2026

“Challenging consumer environment” cited for guidance adjustment.

Continue Reading

Business

More drugs should be over-the-counter

Published

on

More drugs should be over-the-counter
FDA's Marty Makary: Everything should be over-the-counter unless it's unsafe or requires monitoring

Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over-the-counter” unless a drug is unsafe, addictive or requires monitoring – doubling down on a push that some in the pharmaceutical industry have questioned

In an interview on Wednesday in Washington, D.C., Makary said the FDA’s aims to make changes this year that allow more companies to make their prescription medicines available over-the-counter, or OTC. He noted that the agency is going through “the proper regulatory processes” to update OTC monographs –  the rulebooks that determine which drugs can be sold without a prescription. 

Makary said the FDA is looking at “basic, safe” prescription drugs like nausea medications and vaginal estrogen, which is used to treat menopausal symptoms like dryness and pain. 

“In my opinion, everything should be over-the-counter and not requiring a prescription, unless it’s unsafe, unless you need laboratory test to monitor how it’s being received by your body, or if it could be used for some nefarious purpose or it’s addictive,” Makary told CNBC after the PhRMA Forum, a one-day event organized by the pharmaceutical industry’s largest lobbying group. 

Advertisement

“If it doesn’t meet those criteria, why shouldn’t a drug be over the counter? So we should be asking, why not? Instead of, ‘Oh, you want to move over the counter, you got to go through a long, tedious process,’” he added. 

Marty Makary, U.S. President Donald Trump’s nominee to be U.S. Food and Drug Administration (FDA) commissioner, testifies before a Health, Education, Labor, and Pensions (HELP) Senate Committee confirmation hearing on Capitol Hill in Washington, D.C., U.S., March 6, 2025. 

Kent Nishimura | Reuters

The FDA has long considered making some prescription drugs available OTC to improve accessibility, reduce health-care costs and help patients stay on their medications. For example, patients wouldn’t have to take time off work to see a doctor for a prescription or could refill a drug without delay.

Advertisement

Congress boosted the effort through legislation in November that streamlines the regulatory process for prescription-to-OTC transitions, including full, conditional and partial “switch” pathways.

Makary framed the FDA’s latest push to expand OTC access as another way to lower drug costs, a key priority of the Trump administration. He argued that placing medications directly on store shelves would bypass insurers and pharmacy benefit managers, eliminating the rebate-driven system that often obscures a drug’s true price.

He also said selling drugs over the counter promotes transparency that “keeps prices in check.” In some cases, Makary said cash prices for OTC medicines are lower than patients’ copays for prescription drugs “when there’s a money game going on behind the pharmacy counter,” with employers and insurers sharing the cost.

Pharma questions OTC push

Some in the pharmaceutical industry have pushed back on that argument. Most OTC drugs are not covered by insurance, meaning their prices could eclipse those of generic prescription medicines and potentially make them less affordable for patients who rely on coverage. 

Advertisement

In comments to the FDA earlier this month, the Association for Accessible Medicines argued that “the shift of many prescription drugs to nonprescription status could actually increase costs to patients, thereby decreasing patient access to treatments.” That organization represents manufacturers and distributors of generic prescription medicines. 

The FDA also doesn’t have the authority to regulate drug prices. In its own comments this month, PhRMA said the agency must respect “the core principle that pricing considerations may not factor into FDA regulatory decision-making.”

PhRMA added that the FDA should not attempt to transition any prescription drugs to OTC without first consulting manufacturers. But the group emphasized that it supports the FDA’s effort to expand access to crucial medicines. 

In its own comment this month, AstraZeneca said several previous attempts to transition cholesterol-cutting statins to OTC status have been “unsuccessful, with consumers consistently having difficulty making proper self-selection decisions.” 

Advertisement

Meanwhile, Makary told CNBC on Wednesday that “we have to trust people to make their decisions. We’ve got to get away from this paternalistic mindset.”

The FDA removed the longtime director of the office of over-the-counter drugs, Theresa Michele, from her position in December, STAT news reported at the time. 

Continue Reading

Business

Mondelez CEO on the five things that worry him

Published

on

Mondelez CEO on the five things that worry him

Consumer sentiment and ultra-processed foods top the list. 

Continue Reading

Business

More than 150 jobs lost as East Yorkshire maker collapses into administration

Published

on

Business Live

Administrators confirm the Goole-based emergency vehicle manufacturer has shut down after more than 30 years

O&H Vehicle Conversions has filed a notice of intention to appoint administrators

O&H Vehicle Conversions had filed a notice of intention to appoint administrators(Image: O&H Vehicle Conversions)

Hopes that jobs could be saved at a Goole-based manufacturer of emergency vehicles have been dashed after administrators were officially appointed. Insolvency experts were brought in to O&H Vehicle Conversions last week amid financial difficulties.

The development brings to an end more than three decades of production at the firm’s Larsen Road facility, and results in the loss of 157 positions. Administrators from BDO LLP said the business had been affected by delivery delays which impacted revenue and cashflow, with the directors believed to be left with no alternative but to place the company into administration.

Attempts to market the business had been ongoing even before BDO’s appointment but a sale as a solvent, going concern could not be achieved. O&H’s 64,000 sqft plant which manufactured ambulances and other rapid response emergency vehicles is now shut.

Mark Thornton, one of the joint administrators said: “It is always a sad day when a longstanding business is forced to close. Given the financial position and outlook for the company, securing a sale of the business as a going concern was not possible.

Advertisement

“The priority of the joint administrators will now be to support employees impacted by the closure and realise assets in line with our duties in order to maximise the return for creditors.”, reports Hull Live.

The shuttering of O&H comes just weeks after CEO Mark Brickhill released a statement saying that since November of the previous year, approximately £2.2m in sales had been postponed. He stated that O&H had received support from shareholders for years, amounting to over £25m in a “very challenging industry”.

The most recent accounts for O&H Vehicle Conversions Group Ltd, spanning the year up to the end of February 2024, reveal a turnover of £22.3m and operating losses exceeding £9.7m. In those accounts, executives attributed delays to multi-year NHS Trust orders for ambulances which needed new post-Brexit accreditations.

Several O&H employees have taken to social media in recent days in search of new employment opportunities. A former director said: “It’s a difficult day, saying goodbye to so many talented and dedicated colleagues at O&H. People who showed up every day with pride, resilience, and a genuine commitment to doing things the right way. Watching a team like that be broken apart is heart breaking.

Advertisement

“I’m incredibly proud of what we achieved together, and I’m grateful for the friendships, the support, and the professionalism you all brought to work every single day. To everyone affected, I wish you nothing but success in finding your next role and hope our paths cross again. If anyone reading this can help my colleagues into their next opportunity, please do reach out to them.”

Continue Reading

Business

Newcastle Airport boosts global cargo power with expansion

Published

on

Business Live

On-site business partner Samson Aviation has invested in a range of new equipment to handle more cargo

Paula Ives, general manager at Samson Aviation; Liam Adams, Samson operations team leader; David Grace, business development manager at Samson Aviation; Aileen Wallace, cargo business development manager at Newcastle Airport and Leon McQuaid, director of aviation development at Newcastle Airport.

Paula Ives, general manager at Samson Aviation; Liam Adams, Samson operations team leader; David Grace, business development manager at Samson Aviation; Aileen Wallace, cargo business development manager at Newcastle Airport and Leon McQuaid, director of aviation development at Newcastle Airport.(Image: Newcastle Airport.)

Newcastle Airport has strengthened its role as a major logistics hub after expanding cargo services to meet growing demand. The airport’s on-site business partner, Samson Aviation, has invested in a range of new equipment, including a main deck loader capable of handling both widebody and narrowbody passenger and cargo aircraft.

The upgrade enables the airport to handle larger and more specialised cargo, such as heavy machinery, aircraft components, and luxury vehicle, across a wider range of aircraft. The move supports growth beyond the 4,000 tonnes of cargo it currently imports and exports for the region.

The airport supports global trade through its round-the-clock operations and transport connectivity. Emirates’ daily Dubai service can carry up to 21 tonnes of cargo, transporting a wide range of goods including automotive parts and pharmaceuticals.

From Dubai, cargo can be transported to more than 130 destinations worldwide, with Shanghai in China, Melbourne in Australia and Johannesburg in South Africa being among the most popular destinations for exports from Newcastle.

Advertisement

Meanwhile, the freight village offers a range of freight processing facilities, allowing imported goods to be cleared quickly through customs before being transported across the UK and beyond.

A CGI of AirLink, the new new cargo hub earmarked to be built at Newcastle Airport

A CGI of AirLink, the new new cargo hub earmarked to be built at Newcastle Airport(Image: Newcastle Airport)

In its 2040 Masterplan, the airport has outlined plans to further expand its cargo operations, including building AirLink, a new 750,000sq ft cargo hub, which could create thousands of jobs and boost the regional economy by up to £165m a year.

Leon McQuaid, director of aviation development at Newcastle Airport, said: “We are delighted to further strengthen Newcastle Airport’s position as a leading cargo gateway with the addition of this new equipment. It significantly enhances our capability to handle a wider range of cargo and underlines our ability to support the growing number of businesses choosing the Airport for their import and export needs.

“Our continued investment in our cargo infrastructure demonstrates a clear commitment to growth and we continue to welcome conversations with any cargo or aviation related businesses looking to invest in the region.”

Advertisement

Paula Ives, general manager at Samson Aviation, said: “The investment in the new equipment demonstrates Samson Aviation’s commitment to supporting Newcastle Airport’s growing cargo operations. It will create more opportunities for businesses in the North East, across the UK and internationally to transport larger and more specialised cargo efficiently and connect with key markets around the world.”

Continue Reading

Business

Satellite images show Iran repairing and fortifying sites amid US tensions

Published

on

Satellite images show Iran repairing and fortifying sites amid US tensions


Satellite images show Iran repairing and fortifying sites amid US tensions

Continue Reading

Business

Paramount Skydance Raises Bid to $31 Per Share in Renewed Talks With Warner Bros. Discovery

Published

on

Coffee

Warner Bros. Discovery said Tuesday it will reopen takeover talks with Paramount Skydance after the bidder raised its offer to $31 per share, topping its earlier $30 proposal and putting new pressure on a rival deal with Netflix.

The renewed discussions come after Netflix granted Warner a seven-day waiver to explore whether Paramount can submit a stronger and binding offer.

Warner’s board said it will use this short window to address what it called “deficiencies” in Paramount’s prior bids and to clarify key terms.

A senior Paramount representative told a member of Warner’s board that the company is willing to increase its offer to $31 per share and could potentially improve it further.

Advertisement

Paramount has argued that its proposal is financially superior to Netflix’s $27.75 per share deal and more likely to gain approval from federal antitrust regulators, CBS News reported.

Warner CEO David Zaslav said the company has been clear about the issues in Paramount’s earlier proposals.

“We are engaging with [Paramount Skydance] now to determine whether they can deliver an actionable, binding proposal that provides superior value and certainty for WBD shareholders through their best and final offer,” Zaslav said in a statement.

Netflix’s $72 Billion Deal Targets Warner Studio

Under the existing agreement with Netflix, the streaming giant would acquire Warner’s movie studio and streaming assets in a deal valued at $72 billion.

The studio’s film library includes major franchises such as “Harry Potter,” “The Matrix,” and “Casablanca.” Including debt, the enterprise value of the Netflix deal reaches about $83 billion.

Paramount’s approach is broader. It has proposed buying all of Warner Bros. Discovery, including cable networks like CNN, TBS and TNT. According to AP News, its overall bid, including debt, stands at about $108 billion.

Despite reopening talks, Warner’s board continues to recommend that shareholders vote in favor of the Netflix transaction.

Advertisement

A shareholder meeting is scheduled for March 20. Netflix said Warner has until Feb. 23 to negotiate with Paramount before the waiver expires.

In a statement, Netflix expressed confidence in its offer, saying a combined Netflix and Warner would “strengthen the entertainment industry, preserve choice and value for consumers and give creators more opportunities.” The company added that it believes its deal will pass antitrust review.

Investors reacted quickly. Warner shares rose more than 2% in early trading, while Paramount gained over 6%. Netflix stock dipped slightly.

Originally published on vcpost.com

Advertisement

Continue Reading

Trending

Copyright © 2025